Biocrates and Chenomx team up for metabolic profiling technologies

03/10/2010 | GenomeWeb Daily News (free registration)

Austrian biomarker firm Biocrates and Canadian firm Chenomx have entered a deal to integrate their technologies in order to produce metabolic profiling systems that can be used for tracking the effects of disease, drugs and other factors on an organism. Biocrates utilizes a mass spectrometry-based system while Chenomx employs a method based on nuclear magnetic resonance spectroscopy to evaluate biological samples.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL